BostonGene
✓ Verified
Healthcare AI
Precision oncology / molecular and immune profiling
Series B
BostonGene is an AI healthcare and precision oncology company that uses multimodal molecular and immune profiling to support personalized cancer care, drug development, biomarker discovery, and clinical decision-making. Its platform combines bioinformatics with sequencing, flow cytometry, and imaging to generate biologically grounded insights for oncology and immune-mediated diseases.
Company Details
- Website
- bostongene.com
- Headquarters
- Waltham, Massachusetts, United States
- Funding
- $150M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring